MoneyWorks4Me

Everest Organics informs about statement of investor complaints

06 Apr 2017 Evaluate

Everest Organics has informed about Statement of Investor Complaints during the quarter ended 31.03.2017 under regulation 13 (3) of Securities Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..